159 related articles for article (PubMed ID: 11710966)
1. IL-6 signaling by STAT3 participates in the change from hyperplasia to neoplasia in NRP-152 and NRP-154 rat prostatic epithelial cells.
Barton BE; Murphy TF; Adem P; Watson RA; Irwin RJ; Huang HF
BMC Cancer; 2001; 1():19. PubMed ID: 11710966
[TBL] [Abstract][Full Text] [Related]
2. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
[TBL] [Abstract][Full Text] [Related]
3. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines.
Barton BE; Karras JG; Murphy TF; Barton A; Huang HF
Mol Cancer Ther; 2004 Jan; 3(1):11-20. PubMed ID: 14749471
[TBL] [Abstract][Full Text] [Related]
4. STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P.
Horiguchi A; Oya M; Marumo K; Murai M
Kidney Int; 2002 Mar; 61(3):926-38. PubMed ID: 11849447
[TBL] [Abstract][Full Text] [Related]
5. JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells.
De Vos J; Jourdan M; Tarte K; Jasmin C; Klein B
Br J Haematol; 2000 Jun; 109(4):823-8. PubMed ID: 10929036
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6-induced JAK2/STAT3 signaling pathway in endothelial cells is suppressed by hemodynamic flow.
Ni CW; Hsieh HJ; Chao YJ; Wang DL
Am J Physiol Cell Physiol; 2004 Sep; 287(3):C771-80. PubMed ID: 15151905
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells.
Burke WM; Jin X; Lin HJ; Huang M; Liu R; Reynolds RK; Lin J
Oncogene; 2001 Nov; 20(55):7925-34. PubMed ID: 11753675
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
[TBL] [Abstract][Full Text] [Related]
10. [Influence on the cytokines expression on hepatic tissue by inhibition the signal pathway of inflammatory mediators following extensive hepatectomy in rats].
Mao YL; Yu Z; Sang XT; Lu X; Yang ZY; Zhong SX
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(1):6-9. PubMed ID: 15774164
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma.
Aoki Y; Feldman GM; Tosato G
Blood; 2003 Feb; 101(4):1535-42. PubMed ID: 12393476
[TBL] [Abstract][Full Text] [Related]
12. AG490 prevents cell death after exposure of rat astrocytes to hydrogen peroxide or proinflammatory cytokines: involvement of the Jak2/STAT pathway.
Gorina R; Petegnief V; Chamorro A; Planas AM
J Neurochem; 2005 Feb; 92(3):505-18. PubMed ID: 15659221
[TBL] [Abstract][Full Text] [Related]
13. Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury.
Seki Y; Kai H; Shibata R; Nagata T; Yasukawa H; Yoshimura A; Imaizumi T
Circ Res; 2000 Jul; 87(1):12-8. PubMed ID: 10884366
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
Alas S; Bonavida B
Clin Cancer Res; 2003 Jan; 9(1):316-26. PubMed ID: 12538484
[TBL] [Abstract][Full Text] [Related]
15. JAK2/STAT3, not ERK1/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes.
Yu X; Kennedy RH; Liu SJ
J Biol Chem; 2003 May; 278(18):16304-9. PubMed ID: 12595539
[TBL] [Abstract][Full Text] [Related]
16. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor enhances bFGF-induced IL-6 synthesis in osteoblasts: involvement of JAK2/STAT3.
Kozawa O; Otsuka T; Uematsu T
Cell Signal; 2002 Apr; 14(4):311-5. PubMed ID: 11858938
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
Li WQ; Dehnade F; Zafarullah M
J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308
[TBL] [Abstract][Full Text] [Related]
19. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
[TBL] [Abstract][Full Text] [Related]
20. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction.
Negoro S; Kunisada K; Tone E; Funamoto M; Oh H; Kishimoto T; Yamauchi-Takihara K
Cardiovasc Res; 2000 Sep; 47(4):797-805. PubMed ID: 10974228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
